3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
23
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
HIV Infections
1
Anemia, Sickle Cell
1
Interventions
Temozolomide
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiotherapy
4
Radiation
3
trametinib
2
dabrafenib
2
Radiotherapy, Intensity-Modulated
2
Bevacizumab
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
ribociclib
1
Spinal Puncture
1
Protons
1
Proton Therapy
1
Pluvicto
1
Nivolumab
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Flucytosine
1
Everolimus
1
Carboplatin
1
CTLA-4 Antigen
1
AZD1390
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Bortezomib
×
30 days
×
Clear all
No trials found.